期刊文献+

甲型流感病毒血凝素基因HA和HA_1真核载体的构建及其表达研究 被引量:1

Construction of Eukaryotic Expressing Plasmids for HA and HA_1 of Influenza A Virus and Their Transient Expression in HEK293 Cells
下载PDF
导出
摘要 目的构建甲型流感病毒A/PR/8/34(H1N1)血凝素基因HA和HA1真核表达载体,并检测其在HEK293细胞中的表达。方法利用RT-PCR技术克隆流感病毒株血凝素HA和HA1基因片段并插入真核表达载体pcDNA3.1(+)。经酶切、PCR和测序鉴定后用PolyFect脂质体转入HEK293细胞,通过免疫荧光技术检测其瞬时表达。结果血凝素基因HA和HA1的真核表达载体构建成功。转染后免疫荧光技术检测显示两者皆可在HEK293细胞中正确表达。结论成功构建的流感病毒HA和HA1真核表达载体为深入研究病毒的作用机制及核酸疫苗的研究奠定了基础。 Objective To construct influenza A virus (A/PR/8/34) HA and HA1 eukaryotic expressing plasmids and study their expression in HEK293 cells. Methods HA and HA1 genes were cloned by RT-PCR and then inserted into pcDNA3. 1 (+). After identification of restriction enzyme digestion, PCR and sequencing analysis, HA and HA1 eukaryotic expressing plasmids were transfected into HEK293 cells with PolyFect Transfection Reagent. Immunofluorescence assay was used to observe the transient expressing result. Results It was confirmed that the construction of HA and HA1 eukaryotic expressing plasmids was made successfully. The stronger fluorescence signals were detected in transfected HEK293 cells with these two kinds of plasmids by immunofluorescence assay. Conclusion The experiment is a success in the construction of eukaryotic expressing plasmoids for HA and HA1, thus providing a basis for further probing into the mechanism of virus infection and exploring DNA vaccine.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2006年第2期176-179,共4页 Journal of Sichuan University(Medical Sciences)
基金 国家自然科学基金(批准号39970830)资助
关键词 流感病毒 血凝素 PCDNA3.1(+) 免疫荧光技术 Influenza virus Hemagglutinin pcDNA3.1 (+) Immunofluorescence assay
  • 相关文献

参考文献9

二级参考文献62

  • 1[23]Rankin J A, Reynolds H Y. Pulmonary host defenses: humoral immune components, In: Gallin JI, Fauci AS, editors. Advances in host defense mechanisms[M]. vol. 4, New York: Raven; 1985. p115-140.
  • 2[24]Mitchell J A, Green T D, Bright R A, et al. Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins[J]. Vaccine, 2003,21(9-10): 902-914.
  • 3[25]Ross T M, Xu Y, Bright RA, et al. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge[J]. Nat Immunol, 2000, 1(2): 127-131.
  • 4[1]Min W, Lillehoj H S, Burnside J, et al. Adjuvant effects of IL-1beta, IL-2, IL-8, IL-15, IFN-alpha, IFN-gamma TGF-beta4 and lymphotactin on DNA vaccination against Eimeria acervulina[J]. Vaccine, 2001,20(1-2): 267-274.
  • 5[2]Ramsay J, Kohonen-Corish M. Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo[J]. Eur J Immunol, 1993, 23: 3141-3145.
  • 6[3]O'Neill E, Martinez I, Villinger F, et al. Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration[J]. J Med Primatol, 2002,31(4-5): 217-227.
  • 7[4]Grossman M E, Brown M P, Brenner M K. Antimumor response induced by transgenic expression of CD40 ligand[J]. Hum Gene Ther, 1997, 8: 1935-1943.
  • 8[5]Kimm J J, Nottingham L K, Wilson D M, et al. Engineering DNA vaccine codelivery of co-stimulatory molecule genes[J]. Vaccine, 1998,16: 1828-1835.
  • 9[6]Armitage R J, Fanslow W C, Strockbine L, et al. Molecular and biological characterization of a murine ligand for CD40[J]. Nature, 1992, 357: 80-82.
  • 10[7]Banchereau J, Bazan F, Blanchard D, et al. The CD40 antigen and its ligand[J]. Annu Rev Immunol, 1994, 12: 881-922.

共引文献27

同被引文献9

  • 1朱元军,李明远.防御素抗HIV作用[J].国际病毒学杂志,2006,13(1):2-5. 被引量:12
  • 2Lehrer R,Ganz T.Defensine of vertebrate animals[J].Curr Opin Immunol,2002;14:96-102.
  • 3Lehrer B.Innate and adaptive mucosal immunity in protection against HIV infection[J].Vaccine,2003;21(suppl 2):68-76.
  • 4Oppenheim J,Yang D.Alarmins:chemotactic activators of immune responses[J].Current Opinion in Immunology,2005;17:359-365.
  • 5Biragyn A,Tani K,Michael C et al.Genetic fusion of chemokines to a self tumor antigen induces protective T cell dependent antitumor immunity[J].Nature Biotechnology,1999;17:253-258.
  • 6Biragyn A,Coscia M,Adelchi Ruffini P et al.Chemokine receptormediated delivery directs self-tumor antigen efficiently into the class Ⅱ processing pathway in vitro and induces protective immunity in vivo[J].Blood,2004;104:1961-1969.
  • 7Yang D,Biragyn A,W Kwak L et al.Mammalian defensins in immunity:more than just microbicidal[J].Trends in Immunology,2002;23:291-296.
  • 8Leikina E,Delanoe-Ayari H,Lehrer R et al.Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins[J].Nature Immunology,2005;6:995-1002.
  • 9邹丽容,方芳,陈则.编码流感病毒血凝素基因和CD40L的核酸疫苗抗小鼠流感研究[J].中国病毒学,2004,19(2):105-109. 被引量:3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部